Jeremy Pinto
About Jeremy Pinto
Jeremy Pinto serves as an Exceptional Access Program Clinical Pharmacist at the Ontario Ministry of Health and Long-Term Care, specializing in evaluating requests for non-formulary drug products. He has extensive experience in biologics, anti-infectives, and immunomodulators, contributing to patient access to essential medications.
Work at Ontario Ministry of Health and Long-Term Care
Jeremy Pinto serves as an Exceptional Access Program Clinical Pharmacist within the Ontario Public Drug Program. He has held this position since 2015, focusing on evaluating requests for non-formulary drug products, particularly in the areas of oncology and hematology. His role involves ensuring that patients have appropriate access to necessary medications, which is critical for their treatment and health outcomes.
Previous Experience at Ontario Pharmacists Association
Prior to his current role, Pinto worked as a Telehealth Pharmacist at the Ontario Pharmacists Association from 2014 to 2015. In this capacity, he provided pharmaceutical care through telehealth services, enhancing patient access to medication management and advice.
Current Role at Shoppers Drug Mart
Pinto is also employed as a Staff Pharmacist at Shoppers Drug Mart, where he has worked since 2009. His responsibilities include dispensing medications, providing patient consultations, and ensuring safe medication practices in a retail pharmacy setting.
Education and Certifications
Pinto holds a Bachelor of Science in Pharmacy from the University of Alberta, which he completed from 2000 to 2006. He has furthered his education by obtaining the Certified Diabetes Educator designation from the Canadian Diabetes Education Certification Board in 2013, and he completed a Certificate in Geriatric Medication Management through the Ontario Pharmacist Association in 2014.
Specializations in Pharmacy
Pinto specializes in evaluating non-formulary drug requests and has expertise in biologics, anti-infectives, and immunomodulators. His knowledge in these areas supports his work in the Exceptional Access Program, where he assesses the appropriateness of medications for patients with complex health needs.